newsfilter
← Latest News
ClinicalTrials.gov·

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis - NCT04984278

Change in Lower Limb Muscle Tone-6 (LLMT-6) from Day 1 predose to Day 21 (Treatment Period 1) and from Day 31 predose to Day 51 (Treatment Period 2), Change in LLMT-4 from Day 1 predose to Day 21 and from Day 31 predose to Day 51, Number of participants with treatment-emergent adverse events, (and 7 more...)